High materiality9/10
Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Target $100; current price $28.99; Outperform rating from Oppenheimer.
- Outperform rating; PT $100 vs price ~$28.99.
Key facts
- 01
Target: $100
- 02
Posted price: $28.99
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Jay Olson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.